Russian Pharmalicensing Group - News

+7 495 640 5275
info@regulatoryaffairs.ru

PHARMALICENSING NEWS

Keeping clients informed is one of our major priorities. Be the first to get updates on regulatory issues and news.

Russian Pharmaceutical Market: Q3-2015 Results

9 November 2015

At the end of the third quarter of 2015, the growth of the Russian pharmaceutical market has slowed and reduction of its volumes can be seen compared with the beginning of the year: the growth will be only 5.1% in rouble terms relative to the Q3-2014.

The decline of volumes: market volume -7,80%, due to a noticeable fall in the package market of 2014 (-4,5%).

Slowdown in rate of market growth in Q3-2015 due to a slowdown in the growth segment of pharmacy sales of medicinal products: if the 1st half of this segment grew by 22.5%, while in Q3 the growth was only 5.7%.

The drug sales fell in pharmacies, and the decline exceeded -7,5%, whereas in 1st half of 2015 we saw a positive trend. In September the volume of sales in packages decreased by -15%.

In total for 9 months of 2015 the growth amounted to +17.1%.

One of the drivers of market growth is inflation. Inflation for medicines is increasing greater extent by enhancing drug prices in the unregulated sector.

Table 1. Russian Pharmaceutical Market capacity by segments over Q3-2015

Segment

Volume, RUB, mln

Growth

Volume, unit, mln

Growth

Q3-2014

Q3-2015

Q3-2014

Q3-2015

Commercial segment of FPP

157 431

166 346

5,70%

999

925

-7,50%

Parapharmaceuticals

45 217

50 156

10,90%

 

 

 

DLO*

19 691

19 979

1,50%

16

13

-19,10%

Hospital audit

44 694

44 194

-1,10%

204

187

-8,10%

TOTAL

267 033

280 675

5,10%

1 220

1 125

-7,80%

*Drug Reimbursement Program (DLO)

For the 1-3 quarter delivery of medicines under the Drug Reimbursement Program (DLO) increased and amounted to 87 billion roubles, that is 20.7% higher than in 2014. However, there was a decline in in unit (-1.70%) compared with 2014.

The segment of hospital purchases increased by 4% over the 1-3 quarter and amounted to 141 mln rubles. roubles, but in kind medicines were purchased less by 5% than in 2014.

In the first three quarters of 2015 the growth of Russian pharmaceutical market a total amounted to 14.3% in rubles and -1,8% in unit.

Table 2. Russian Pharmaceutical Market capacity by segments over Q 1-3 2015

Segment

Volume, RUB, mln

Growth

Volume, unit, mln

Growth

Q1-3 2014

Q1-3 2015

Q1-3 2014

Q1-3 2015

Commercial segment of FPP

472 342

553 102

17,10%

3 063

3 031

-1,00%

Parapharmaceuticals

132 324

147 541

11,50%

 

 

 

DLO

72 333

87 273

20,70%

56

55

-1,70%

Hospital audit

136 370

141 825

4,00%

686

651

-5,00%

TOTAL

813 369

929 740

14,30%

3 805

3 738

-1,80%


Source: DSM Group   back to headlines